Valuation: Olympus Corporation

Market Cap 1,830B 11.17B 9.82B 9.12B 8.39B 15.74B 1,082B 16.02B 109B 42.56B 528B 41.93B 41.02B P/E 2027 *
18.9x
P/E 2028 * 15.7x
Enterprise Value 1,901B 11.6B 10.2B 9.48B 8.72B 16.34B 1,123B 16.64B 113B 44.2B 548B 43.54B 42.6B EV / Sales 2027 *
1.78x
EV / Sales 2028 * 1.7x
Free-Float
94.53%
Yield 2027 *
1.79%
Yield 2028 * 1.87%
1 day-0.17%
1 week-1.37%
Current month+1.41%
1 month+3.64%
3 months+10.52%
6 months-8.57%
Current year-13.18%
1 week 1,703
Extreme 1703
1,790
1 month 1,621
Extreme 1621
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%-1.37%+2.87%-22.74% 11.24B
+8.71%+6.92%+33.84%+1.80% 196B
+7.46%-4.13%+1.36%-24.77% 126B
-2.54%-14.64%-35.03%-1.38% 120B
+1.42%+1.25%-57.75%-18.02% 63.87B
-0.65%-3.95%+9.86%-9.45% 48.58B
-1.56%-2.07%-25.50%-33.72% 43.93B
+4.71%+3.73%+20.27%+9.50% 37.69B
+3.13%+2.00%+33.03%+32.45% 36.41B
+3.14%+5.19%+92.94%+3.34% 28.88B
Average +2.22%-3.17%+7.59%-6.30% 71.25B
Weighted average by Cap. +3.73%-4.93%+4.11%-6.52%

Financials

2027 *2028 *
Net sales 1,067B 6.51B 5.72B 5.32B 4.89B 9.17B 630B 9.34B 63.6B 24.81B 307B 24.44B 23.91B 1,108B 6.76B 5.95B 5.52B 5.08B 9.53B 655B 9.7B 66.06B 25.77B 319B 25.38B 24.83B
Net income 98.73B 602M 530M 492M 453M 849M 58.34B 864M 5.89B 2.3B 28.46B 2.26B 2.21B 118B 718M 632M 587M 540M 1.01B 69.56B 1.03B 7.02B 2.74B 33.93B 2.7B 2.64B
Net Debt 70.42B 430M 378M 351M 323M 606M 41.62B 616M 4.2B 1.64B 20.3B 1.61B 1.58B 52.07B 318M 279M 260M 239M 448M 30.77B 456M 3.1B 1.21B 15.01B 1.19B 1.17B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-23 ¥1,723.00 -0.17% 4,138,900
26-07-22 ¥1,726.00 -1.65% 4,597,100
26-07-21 ¥1,755.00 -0.93% 4,092,100
26-07-17 ¥1,771.50 +1.40% 6,334,600
26-07-16 ¥1,747.00 0.00% 3,845,700
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,723.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+11.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock